Trials / Completed
CompletedNCT01896388
Ifenprodil Tartrate Treatment of Adolescents With Post-traumatic Stress Disorder: a Double-blind, Placebo-controlled Trial
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Chiba University · Academic / Other
- Sex
- All
- Age
- 13 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
Accumulating evidence suggests a key role of the N-methyl-D-aspartate (NMDA) receptor in the pathophysiology of post-traumatic stress disorder (PTSD). Recent studies suggest that the NMDA receptor antagonist ifenprodil tartrate may be a potential therapeutic drug for PTSD. The purpose of this study is to confirm whether ifenprodil tartrate is effective in the treatment of adolescents PTSD patients. If ifenprodil tartrate is effective in these patients, this study contributes to the development of novel therapeutic drugs for PTSD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ifenprodil Tartrate | |
| DRUG | Placebo |
Timeline
- Start date
- 2014-01-21
- Primary completion
- 2019-03-01
- Completion
- 2019-03-01
- First posted
- 2013-07-11
- Last updated
- 2019-03-19
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01896388. Inclusion in this directory is not an endorsement.